
Petros Karakousis, MD
Infectious Diseases
Highlights
Age Groups Seen
- Young Adult 18-25
- Adult 26-64
- Older Adult 65+
Languages
- Russian
- German
- Spanish
- Greek
- English
In-Network Plans
View All Accepted Plans (12)Gender
MaleJohns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Petros Karakousis
Primary Academic Title
Professor of Medicine
Johns Hopkins Physician
Background
Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis.
Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005.
His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies.
Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies
Centers and Institutes
Tuberculosis Research Advancement Center
Center for Tuberculosis Research
Contact for Research Inquiries
1551 E. Jefferson Street, Rm 110
Baltimore, MD 21287-0014
Phone: (410) 502-8233
petros@jhmi.edu
Research Interests
Tuberculosis pathogenesis, Mycobacterium tuberculosis persistence, Host-directed therapies, COVID-19 pathogenesis
Lab Website
Karakousis Lab - Lab Website
The primary focus of the Karakousis Lab is to understand the molecular basis of Mycobacterium tuberculosis latency and reactivation.
Major research activities include studying the adaptation of M. tuberculosis to stress conditions believed to be important in the infected human host, as well as the phenomenon of phenotypic tolerance to antibiotics. In particular, the regulatory cascade involved in the mycobacterial stringent response is under active investigation. A systems biology-based approach is being used to identify host cytokine networks responsible for immunological control of M. tuberculosis growth, as well as M. tuberculosis regulatory and metabolic pathways required for bacillary growth restriction and reactivation.
The laboratory is also actively involved in preclinical drug screening in physiologically relevant animal models.
A third focus of the laboratory is the development of novel molecular assays for the rapid diagnosis of latent TB infection and active TB disease, and for the detection of drug resistance. Specifically, molecular assays using blood, sputum, and urine samples are being investigated with the goal of developing rapid, sensitive and specific point-of-care tests for TB diagnosis and detection of drug resistance.
Selected Publications
Chuang Y-M, Bandyopadhyay N, Rifat D, Rubin H, Bader JS, Karakousis PC. “Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis.” mBio. 2015;6(2).
Levine DM, Dutta NK, Eckels J, Scanga C, Stein C, Mehra S, Kaushal D, Karakousis PC, Salamon H. “A tuberculosis ontology for host systems biology.” Tuberculosis. 2015;95(5):570-574.
Subbian S, Tsenova L, Kim M-J, Wainwright HC, Visser A, Bandyopadhyay N, Bader JS, Karakousis PC, Murrmann GB, Bekker LG, et al. “Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: A pilot study.” PLoS ONE. 2015;10(7).
Xu Z, Zhou A, Ni J, Zhang Q, Wang Y, Lu J, Wu W, Karakousis PC, Lu S, Yao Y. “Differential expression of miRNAs and their relation to active tuberculosis.” Tuberculosis. 2015;95(4):395-403.
Zhou A, Ni J, Xu Z, Wang Y, Zhang H, Wu W, Lu S, Karakousis PC, Yao Y-F. “Metabolomics specificity of tuberculosis plasma revealed by 1(H) NMR spectroscopy.” Tuberculosis. 2015;95(3):294-302.
Honors
- Fellow, Infectious Diseases Society of America, 1/1/10
- Basic Research Junior Faculty Award, Johns Hopkins, 1/1/09
- Basic Research Junior Faculty Award Finalist, Johns Hopkins, 1/1/08
- Arthur M. Dannenberg, Jr. Award for Postdoctoral Research, 1/1/05
- Best Abstract, Assembly of Microbiology, Tuberculosis, and Pulmonary Infections, American Thoracic Society Annual Meeting, 1/1/04
- Travel Grant to ATS Annual Meeting, American Thoracic Society, 1/1/04
- Basic Research Postdoctoral Fellow Award Nominee, Johns Hopkins, 1/1/04
Graduate Program Affiliations
-
Graduate Program in Pathobiology
-
Cellular and Molecular Medicine
Memberships
- American Thoracic Society
- American Society for Microbiology
- Infectious Disease Society of America
- American College of Physicians
Professional Activities
- Johns Hopkins University-University of Patras, Greece, Hopkins Hellenic Initiative Board Member, 5/1/07
- Journal of Infectious Diseases, Editorial Advisory Board, 5/1/13
- Office of Faculty Development, Senior Advisory Council, 1/1/14
- PLoS One, Academic Editor, 9/1/11
- Reappointment Review Committee, Instructor/Assistant Professor, 5/1/14
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- Get Directions
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
- Fellowship: Johns Hopkins University School of Medicine, Infectious Diseases, 2005
- Residency: Hospital of the University of Pennsylvania , Internal Medicine, 2001
- Medical Education: Washington University School of Medicine, MD, 1998
Board Certifications
- Infectious Disease: American Board of Internal Medicine, 2005
Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- Veteran Affairs Community Care Network (Optum-VACCN)